Net Good IndexSubmit a correction

Benefit Ledger · provisional · Medicine & Health

Novo Nordisk Partners With Anthropic on Drug Discovery and Software Development - citybiz

Novo Nordisk Partners With Anthropic on Drug Discovery and Software Development  citybiz

Tier 1 UsefulMethodology 0.2
Submit a correction

Current score

+0.07

1 base · Useful (tier 1 of 5, 1 pts)
× 0.7500 attribution · Critical contribution
× 0.4500 evidence · External expert evaluation
× 0.4000 realization · Demonstrated
× 0.5000 durability · Medium-term
Event-level product before credit split: 0.07

Ingest update: raised attribution; raised evidence; raised realization. Score remains provisional until review. Follow-up ingest: independent source raised evidence; added a follow-up source. Follow-up ingest: independent source raised evidence; added a follow-up source. Follow-up ingest: independent source raised evidence; added a follow-up source.

What happened

Novo Nordisk Partners With Anthropic on Drug Discovery and Software Development  citybiz Update (2026-09-16): Novo Nordisk Partners With Anthropic on Drug Discovery and Software Development - citybiz. Novo Nordisk Partners With Anthropic on Drug Discovery and Software Development  citybiz Update (2026-09-18): Novo Nordisk Partners with Anthropic on Drug Discovery, Aiming to Shorten Development Timelines with AI - finance.biggo.com. Novo Nordisk Partners with Anthropic on Drug Discovery, Aiming to Shorten Development Timelines with AI  finance.biggo.com Update (2026-09-23): Gene-Editing Stocks Slide as Anthropic Reports AI Discovery With CRISPR-Like Features - citybiz. Gene-Editing Stocks Slide as Anthropic Reports AI Discovery With CRISPR-Like Features  citybiz Update (2026-09-24): Anthropic AI Discovery Gene-Editing Stocks Falling - finance.yahoo.com. Anthropic AI Discovery Gene-Editing Stocks Falling  finance.yahoo.com

Model attribution

Unspecified AI system
Version unspecified
+0.07

Unspecified

Unspecified system mentioned or implied by a news item. Remap to a named release when identified.

News ingest does not infer a named model from the publisher alone. Attribution stays unspecified until a release is identified.

Attribution 0.7500 · Credit share 100% · Unknown

Claims

  • Novo Nordisk Partners With Anthropic on Drug Discovery and Software Development - citybiz

    outcome · supported

Sources

primary sources

other sources

Revision history

  • 17 Sep 2026 · 0.00 → 0.00

    Auto-published from news ingest.

  • 17 Sep 2026 · 0.00 → 0.02

    Ingest update: raised attribution; raised evidence; raised realization.

  • 18 Sep 2026 · 0.02 → 0.04

    Ingest update: independent source raised evidence; added a follow-up source.

  • 23 Sep 2026 · 0.04 → 0.05

    Ingest update: independent source raised evidence; added a follow-up source.

  • 24 Sep 2026 · 0.05 → 0.07

    Ingest update: independent source raised evidence; added a follow-up source.

Submit a correction